South Plains Financial Director Richard D. Campbell Reports $2.31 Million Disposal of Common Shares
Bitget2026/11/06 00:28- South Plains Financial director Richard D. Campbell reported sales of 52,557 common shares held indirectly through Henry TAW from Nov. 3-5, 2026.
- The Nov. 3 sale covered 18,848 shares at $43.61 per share.
- On Nov. 4, 15,900 shares sold at $44.02 per share.
- The Nov. 5 transaction involved 17,809 shares at $44.06 per share.
- Remaining holdings totaled 1,332,412 shares through Henry TAW, 40,000 through RIG and 10,384 directly.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Rocket Lab’s stock falls as quarterly loss exceeds expectations
BUZZ-Take-Two shares rise after raising annual revenue and profit forecasts
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Crypto prices
More
